Zhong Guo Ji Jin Bao·2025-11-04 05:00Market Overview - The A-share market experienced a decline in the morning session, with the Shanghai Composite Index down 0.19%, Shenzhen Component Index down 1.27%, and ChiNext Index down 1.51% [2][3] - The total trading volume in the Shanghai and Shenzhen markets was 1.22 trillion yuan, a decrease of 164.8 billion yuan compared to the previous trading day [3] Banking Sector Performance - The banking sector showed strong performance, with all A-share bank stocks rising. Notable increases included China Merchants Bank up 2.92% and Industrial Bank up over 3% [4][5] - Key bank stock performances included: - Agricultural Bank of China: 8.17 yuan, up 2.00%, market cap 2779.2 billion yuan, YTD change 59.87% - Industrial and Commercial Bank of China: 8.10 yuan, up 2.53%, market cap 2679.2 billion yuan, YTD change 21.97% [5] - Hong Kong-listed bank stocks also saw gains, with China Merchants Bank up over 3% [4][6] Insurance Sector Performance - The insurance sector also performed well, with major A-share insurers like China Life and New China Life rising over 1% [7] - The five major A-share listed insurance companies reported a combined operating income of 23,739.81 billion yuan, a year-on-year increase of 13.6%, and a net profit of 4,260.39 billion yuan, up 33.5% [8] Gold Sector Performance - The gold sector faced a collective decline, with stocks like Shengda Resources down over 5% and several others down more than 3% [11][12] - Specific stock performances included: - Shengda Resources: 22.04 yuan, down 5.00%, market cap 15.2 billion yuan, YTD change 85.01% - Zhongjin Gold: 21.05 yuan, down 3.57%, market cap 102 billion yuan, YTD change 79.70% [12] Innovative Drug Sector Performance - The innovative drug sector saw significant declines, with stocks like Hengrui Medicine down over 1.15% [13] - Notable declines included: - Changshan Pharmaceutical: 57.87 yuan, down 17.09%, market cap 53.2 billion yuan, YTD change 189.49% - Haicheng Pharmaceutical: 56.11 yuan, down 8.14%, market cap 6.7 billion yuan, YTD change 179.14% [14] - The recent national medical insurance negotiations introduced a "commercial insurance innovative drug directory" mechanism, indicating a shift towards multi-tiered healthcare coverage [16]